Cyclerion Therapeutics, Inc. (CYCN)

Price & Market Data

Price: $3.12

Daily Change: -$0.0428 / 1.37%

Daily Range: $2.91 - $3.35

Market Cap: $13,770,399

Daily Volume: 37,488

Performance Metrics

1 Week: 6.54%

1 Month: 7.59%

3 Months: 152.7%

6 Months: 131.2%

1 Year: 3.66%

YTD: 160.8%

About Cyclerion Therapeutics, Inc. (CYCN)

All the market information you need for Cyclerion Therapeutics, Inc. (CYCN). Price: 3.12, daily change: -$0.0428 / 1.37%. Market cap: 13,770,399. Full performance overview, including 3-month, 6-month, and 1-year.

Company Details

Employees: 1

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Selected stocks

Aether Holdings, Inc. (ATHR)

Coherus Oncology, Inc. (CHRS)

RedCloud Holdings plc (RCT)

BrilliA Inc (BRIA)

Eagle Point Credit Company Inc. (ECC)